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Abstract:  
Background: It is unclear how many incident patients with stage 5 chronic kidney disease 
(CKD) referred to Nephrologists are presented with information about conservative care as a 
treatment option and how many choose not to dialyze.  
Study Design: National prospective observational study with random effects logistic 
regression. Clinicaltrials.gov identifier: NCT01298115. 
Setting and participants: Incident adult and pediatric pre-emptive transplant, dialysis and 
conservative care patients from public and private renal units in Australia, July-September 
2009.  
Predictors: Age, sex, health insurance status, language, time known to nephrologist, timing 
of information, presence of caregiver, unit conservative care pathway and size of unit.  
Outcomes & Measurements: Information provision to incident patients about conservative 
care (model 1). Initial treatment, conservative care or not, (model 2).  
Results: Sixty-six of 73 renal units (90%) participated. Ten (15%) had a formal conservative 
care pathway. Of 721 incident stage 5 CKD patients, 470 (65%) were presented with 
conservative care as a treatment option, and 102 (14%) chose not to dialyze, median age 80 
years. Multivariate analysis for information provision (model 1) showed patients over 65 
years, OR 3.40(CI 1.97-5.87) and those known to a nephrologist for more than three months, 
OR 6.50(CI 3.18-13.30) were more likely to receive information about conservative care. 
Patients with conservative care as initial treatment (model 2) were more likely over 65 years, 
OR 4.71(CI 1.77-12.49) and female, OR 2.23(CI 1.23-4.02) than those who commenced 
dialysis. Those with private health insurance were less likely to forgo dialysis OR 0.40(CI 
0.17-0.98). 
Limitations: Cross-sectional design prohibited longer term outcome measurement. Excluded 
stage 5 CKD patients managed in the community.  
Conclusions: One in seven stage 5 CKD patients referred to nephrologists choose not to 
dialyze. Comprehensive service provision with integrated palliative care needs to be 
improved to meet the demands of the aging population.     
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Introduction:  
 
The treatment options for stage 5 chronic kidney disease (CKD) include kidney 
transplantation, dialysis, and supportive non-dialytic therapy often referred to as palliative or 
conservative care. The utilization of transplantation and dialysis is well documented through 
country-specific registries;
1-3
 however the uptake of conservative care for patients who 
choose not to dialyze is unclear. In the United States in 2008, the fastest growing cohort of 
patients accepted onto dialysis was in the 75+ age group, with more than 5,500 prevalent 
dialysis patients aged over ninety years.
2,4
 Data from single-center studies suggest that those 
who choose to forgo dialysis are generally older, of lower socioeconomic status,  and more 
likely to have diabetes mellitus, than patients treated with dialysis.
5-7
  
 
Clinical practice guidelines in the United States, United Kingdom and Australia recommend 
all patients approaching end-stage kidney disease (ESKD) be informed about their treatment 
options including the option of conservative care.
8-11
 The rationale is that patients’ treatment 
decisions should be based on an accurate understanding of their condition and the harms and 
benefits of each treatment pathway. In response to the growing number of elderly on dialysis, 
the US Renal Physicians Association published a specific guideline called “Shared decision 
making in the appropriate initiation of and withdrawal from dialysis.”12 This guideline 
acknowledges that patients have different goals for their care, and that communication of 
prognostic information with the patient, their family and renal team is required to develop a 
consensus on these goals. In circumstances where dialysis does not offer an expectation of 
benefit the option of conservative care may be preferable.  
 
The number of stage 5 CKD pre-dialysis patients that are presented with the option of 
conservative care is unclear. The objectives of this study were therefore to determine the 
national proportion and characteristics of patients approaching ESKD that are educated about 
conservative care as a treatment option; the characteristics of patients who choose 
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conservative care and the number of Australian renal units with a formalized conservative 
care pathway. 
 
Methods: 
We conducted a prospective national cross-sectional study including all incident stage 5 
CKD patients identified during a three month period (the PINOT study). All Australian adult 
and paediatric renal units and private nephrology practices that contribute to the Australia 
and New Zealand Dialysis and Transplant Association registry (ANZDATA, 
www.anzdata.org.au) were invited to participate. Nephrologists and CKD coordinators 
completed a web-based survey detailing the initial treatment for each incident stage 5 CKD 
patient that presented to their unit between 1
st
 July and 30
th
 September 2009. Detailed 
methods and a copy of the survey have been reported elsewhere,
13
 and are listed on the 
clinicaltrials.gov database, identifier # NCT01298115. We defined the sub-group of 
conservative care patients for analysis a priori.
13,14
  The study was approved by the 
University of Sydney Human Research Ethics Committee (protocol #11261) and relevant 
hospital ethics committees. 
 
Renal replacement therapy (RRT) was defined as the initiation of chronic dialysis, or pre-
emptive transplantation within the three month study period. Patients were defined as 
receiving ‘conservative care’ if a confirmed decision had been made not to dialyze, their 
eGFR using the Modification of Diet in Renal disease (MDRD) equation was 
<15ml/min/1.73m
2
 on consecutive measurements, and they did not commence dialysis 
within the three month study period. Patients who withdrew from dialysis were not included. 
Data pertaining to the presentation of treatment options and initial therapy was sourced by 
nephrologists, pre-dialysis and transplant coordinators using pre-existing databases. Specific 
encouragement was given to nephrology heads of department to report conservative care 
patients not routinely seen by those coordinating dialysis or transplant education. 
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Nephrology heads of department were also asked about the presence of a written and 
documented conservative care pathway in their unit.  
 
Source data verification was undertaken by RLM in high recruiting centers in four Australian 
states. Additionally, completion of the surveys by a second renal unit clinician was 
undertaken for 20% of the total sample. Observer agreement of the proportion receiving 
information about their treatment options was performed by two clinicians and reported 
using a kappa statistic.
15
  
 
 
Statistical methods  
To measure patient and unit characteristics associated with provision of information about 
conservative care (model 1) we used random effects logistic regression. The characteristics 
assessed included initial treatment (RRT or conservative care); age (which was categorized 
as <65 years, 65-74 years, 75-84 years and ≥ 85 years, consistent with registry cohorts); sex; 
health insurance status (categorized as public only, private and Department of Veterans’ 
Affairs); language spoken at home (categorized as English speaking, non-English speaking 
with no interpreter; and non-English speaking with an interpreter); time known to a 
nephrologist, (categorized as <3 months, 3-12 months, 1-2 years and >2 years); stage of 
CKD when information about treatment options was first presented, (categorized as stage 5, 
or stages 2-4); attendance of a support person (‘caregiver present’), at presentation of 
information about treatment options; a formal conservative care pathway in the unit; and unit 
size (categorized by the number of prevalent dialysis patients in the preceding year: small 
<100, medium 100-199 and large ≥200). All covariates were included individually and then 
combined in a multivariable model. Random effects were used to account for the clustering 
of patients within units, whose responses may be correlated.  Association was measured 
using odds ratios (OR) to compare the odds of being presented with conservative care 
information for an individual with the characteristic, to another individual without the 
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characteristic at the same renal unit.  Likelihood ratio p-values were used to test the 
associations.  The intraclass correlation (ρ) was estimated using the method described by 
Snijders.
16
 
 
To assess the association between commencing conservative care compared to commencing 
renal replacement therapy (model 2) the same approach was used. Age, sex, insurance status, 
language spoken at home, time known to a nephrologist, stage of CKD, whether a caregiver 
was present, conservative care pathway in unit and unit size were included, both individually 
and in multivariable analysis.  Wald tests were used to test for differences between the levels 
of categories within the multivariable model. Missing covariate values were included in an 
“unknown” category in the models.  All analyses were conducted in Stata/IC 11.1 
(www.stata.com).  
 
Results:  
Sixty-six of 73 (90%) Australian renal units participated. (Table 1) Ten of 66 (15%) had a 
formal (written and documented) conservative care pathway for CKD patients. Non-
participating centers included two pediatric renal units and five small private nephrology 
practices with the main reason for non-participation being lack of physician time to examine 
patient databases. Inter-observer agreement kappa was 89%. Throughout the three month 
study period, 721 incident stage 5 CKD patients were identified. (Table 1) Of interest, 102 of 
721 (14%) patients chose conservative care, i.e. one in 7 patients. (Figure 1) The median age 
for the conservative care group was 80 years, with the youngest aged 47 years and the oldest 
aged 94 years. (Table 1) Most did not have private health insurance and most were known to 
their nephrologist for longer than two years. None of the conservative patients commenced 
dialysis within the three month study period or had plans to commence dialysis in the 
foreseeable future. 
 
Information about conservative care 
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All 721 incident stage 5 CKD patients were included in each analysis. Four hundred and 
seventy of 721 (65%) patients were presented with conservative care as a treatment option. 
In model 1, the multivariable analysis of characteristics associated with the presentation of 
conservative care as a treatment option, increasing age was a significant factor. Compared to 
patients less than 65 years of age, patients aged 65-74 (OR 3.40), 75-84 (OR 5.55) and 
patients aged 85 and over (OR 10.56) were more likely to be presented with conservative 
care than not. (Table 2, Figure 2) Compared to patients known to a nephrologist for less than 
3 months (i.e. late referrals), patients known between 3-12 months (OR 6.50), 1-2 years (OR 
5.67) and > 2 years (OR 3.14) were more likely to receive information about conservative 
care than not.  The likelihood of receiving this information fell steadily after 12 months as 
the odds were significantly lower for patients known for > 2 years compared to those known 
for 3-12 months (Wald p=0.02).  
  
The timing of information about treatment options was significantly associated with the 
presentation of a conservative option.  Patients who were informed of their treatment options 
early, in stage 2-4 CKD (OR 1.01) were more likely to be presented with conservative care 
than those who were presented with information in stage 5, or those in whom it was 
unknown (OR 0.13) if they received information about treatment options prior to starting 
treatment. (Table 2, Figure 2) Patients without an accompanying caregiver (OR 0.62) or with 
caregiver unknown (OR 0.20) were less likely to receive information about conservative 
care. The intraclass correlation (ρ=0.30, 95%CI, 0.18-0.45) showed that there was 
considerable similarity among patients within the same renal unit regarding whether they 
were presented with conservative care as a treatment option.  
 
Patients who commenced conservative care 
In model 2 the multivariable analysis compared characteristics of patients who commenced 
conservative care to those who commenced RRT. (Table 3, Figure 3) Compared to patients 
less than 65 years of age, patients aged 65-74 (OR 4.71), 75-84 (OR 23.11), and patients 
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aged 85 and over (OR 87.44), were more likely to be managed conservatively than start 
RRT. Females were twice as likely (OR 2.23) to commence conservative care than males. 
Patients with private health insurance (OR 0.40) were less likely to commence conservative 
care.  Similar levels of intraclass correlation were found for this model showing that there 
was considerable similarity among patients within the same renal unit regarding their initial 
treatment. Data from the survey revealed the primary reason for not initiating dialysis in the 
conservative care group was patient choice (27% of cases) followed by the presence of 
severe co-morbid conditions. (Table 4) Ten of 102 (10%) conservative patients were referred 
to a palliative care team.  
 
Discussion: 
Our study showed that despite only 15% of renal units having a formal conservative care 
pathway, two-thirds of patients approaching ESKD were presented with information about 
conservative care as a treatment option. These patients were more likely to be older, have a 
caregiver and be well known to their nephrologist compared to patients not presented with 
this option. One in 7(14%) of all incident stage 5 CKD patients chose conservative care and 
were more likely to be older, female and have no private health insurance, compared to those 
who commenced RRT. Patient choice was the most common reason reported for 
conservative care management.  
 
These results highlight several new findings. Firstly and most importantly, our data quantify 
the large national demand for renal conservative care service provision. In Australia, like 
many other countries, few structured conservative care pathways exist in renal units, and the 
referral rate of renal patients to other palliative care services is low. Our data indicate that 
one in 7 patients with ESKD managed in renal units choose not to dialyse, which represents 
a large demand on the limited existing conservative care services. Traditionally renal 
services have concentrated efforts and paramedical support services on the provision of renal 
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replacement therapy; however it would appear from this data that the focus needs to shift to 
include support and options for non-dialytic care. 
 
Second, our data suggest patients who choose conservative care may be different to those 
who choose RRT.  Females were twice as likely to commence conservative care when 
adjusted for all other factors.  This trend has also been observed in dialysis withdrawal where 
females were more likely to withdraw from dialysis than males.
17
  Historically women in the 
United States and Sweden had only 70-90% chance of receiving renal replacement therapy 
compared to men;
18
 and more recently in Hong Kong a male to female renal conservative 
care ratio of 1 to1.14 was reported.
5
  This association was not observed in two observational 
studies of conservative patients in the United Kingdom, 
19,20
 however  the finding is 
consistent with evidence from other chronic diseases suggesting that men may be more likely 
than women to be treated with active intervention than medical management, (for example 
carotid endarterectomy for stroke prevention).
21
 
 
Patients with private health insurance (including war veterans insurance) were also less 
likely to commence conservative care. War veterans and war widows in Australia typically 
receive comprehensive health care coverage which includes subsidized transport to attend 
dialysis, and admission to private dialysis centres. Likewise privately insured patients have 
easier access to dialysis facilities used by their chosen specialist, with no out-of-pocket costs, 
which may make the choice to dialyze more attractive.
22
 If we assume that private health 
insurance is a proxy for higher socioeconomic status then these results are consistent with 
Yong et al
5
 who found conservatively managed patients in Hong Kong lived in public 
housing, and were financially dependent on their families, when compared to patients treated 
with dialysis. What is interesting is that private health insurance still has an effect on dialysis 
uptake, in a country where the costs of treatment are largely borne by the government.  
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Third, we found the longer CKD patients were known to their nephrologist (beyond 12 
months) the likelihood of a conservative care discussion decreased. This association may 
represent patients with slow progressive CKD, particularly in the elderly, where other 
competing risks of death such as cancer and cardiovascular disease exceed the risk of 
progression to the point of requiring RRT.
23
 Nephrologists might weigh up the benefits and 
harms of starting discussions about treatment options including conservative care, and delay 
such conversations until the patient becomes symptomatic. Alternatively it may reflect 
complacency on the part of the renal team, in assuming the patient has knowledge of their 
treatment options, including conservative care, related to their length of time with CKD. 
 
International guidelines recommend conservative care or palliative services should extend to 
non-malignant diseases such as cardiac, liver and renal disease. However one of the practical 
barriers to access of palliative care services in renal units includes too few palliative care 
physicians. One response to this is a model of care whereby staff nephrologists are trained in 
aspects of palliative care including symptom assessment and symptom treatment, advance 
care planning, and referral of dying patients to hospice services. 
24,25,26
 A second model of 
care integrates palliative care physicians into renal clinics, who then take the lead with 
management of uremic symptoms, and discussions about end of life care.
27,28
 In general, care 
pathways aim to ensure that the most appropriate management occurs at the most appropriate 
time and that it is provided by the most appropriate health professional.
29
 For conservatively 
managed patients, care pathways can clarify treatment options in end-stage disease, reduce 
the ambiguity surrounding decision-making and reduce a sense of abandonment from the 
renal team.
30,31
 Benefits to clinicians include improved multidisciplinary communication and 
increased use of best practice.
32
  Whichever approach is taken, conservative care pathways 
for renal patients need to be well-funded, coordinated and subjected to routine evaluation and 
audit.  
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The limitations of this study include the cross-sectional design and the non-participation of a 
small number of renal units which could induce selection bias. We do not have long-term 
follow up data to assess whether the 102 conservative patients commenced dialysis within 
the subsequent 12-24 month period. We know there were no plans for these patients to 
commence dialysis in the foreseeable future and other longitudinal studies have shown the 
majority of patients do not cross over from conservative care to the renal replacement 
therapy at the last minute, if well prepared and fully informed about their treatment options. 
5,7,33
 Our study was also limited to incident stage 5 CKD patients managed conservatively by 
nephrologists (i.e. not in the community). Therefore the total numbers choosing conservative 
care are likely to be an under-estimate of the total incidence of conservative care in CKD.  
 
Our study has many strengths. We achieved an extremely high national participation rate 
with 66 (90%) of all renal centers involved ensuring the study population was reflective of 
the Australian CKD population and likely generalizable to stage 5 patients in the United 
States and Europe where options for conservative treatment exist. We used robust statistical 
methods to assess associations, and to our knowledge are the first study to report a nation-
wide figure for the proportion of patients that choose not to dialyze, and the first to examine 
the provision of information about conservative care to incident stage 5 patients.  
 
The number of conservative care patients seen by nephrologists is expected to increase, due 
to both the population increase in people with ESKD over 75 years of age, and the 
proportion of patients with multiple comorbidities, in whom dialysis may provide little 
survival benefit.  Further research is needed in the area of treatment decision making and 
evaluation of emerging models of palliative care service provision. Large multi-centre cohort 
studies would help address questions of survival and quality of life in those who choose not 
to dialyze. In addition, the formal evaluation of patient preferences for conservative care 
compared to dialysis, would provide evidence to support policy in this area. 
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One in seven stage 5 CKD patients referred to nephrologists choose not to dialyze, which 
represents a large demand on the limited existing renal services. Comprehensive service 
provision with integrated palliative care needs to be improved to meet the demands of the 
aging population.     
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Table 1: Patient and unit characteristics of the conservative care group and renal replacement 
therapy (RRT) group  
 Conservative care RRT 
 n =102 (%) n =619 (%) 
Patient characteristics      
Age (years) Mean (sd) 79 (8.7)  61 (17.3)  
 Median (IQR) 80 (9.8)  64 (24)  
Age group (years) 0-44 0 (0) 107 (17) 
 45-54 2 (2) 90 (15) 
 55-64 6 (6) 125 (20) 
 65-74 16 (16) 149 (24) 
 75-84 52 (51) 127 (21) 
 ≥85 26 (25) 21 (3) 
Sex Male 52 (51) 371 (60) 
 Female 50 (49) 248 (40) 
Type of insurance Public only 57 (56) 418 (68) 
 Private 13 (13) 136 (22) 
 DVA
*
 5 (5) 19 (3) 
 Unknown 27 (26) 46 (7) 
Language spoken at home English 83 (81) 491 (79) 
 Vietnamese 6 (6) 12 (2) 
 Italian 5 (5) 21 (3) 
 Greek 2 (2) 11 (2) 
 Arabic 1 (1) 3 (0) 
 Other 5 (5) 81 (13) 
Interpreter required Yes 11 (11) 59 (10) 
Time known to nephrologist < 3 months 15 (15) 142 (23) 
 3-12 months 15 (15) 111 (18) 
 1-2 years 18 (18) 114 (18) 
 > 2 years 54 (53) 252 (41) 
Stage of CKD when information first 
presented 
Stage 5 49 (48) 369 (60) 
 Stages 2-4 40 (39) 185 (30) 
 Unknown 13 (13) 65 (11) 
Caregiver present Yes 66 (65) 399 (64) 
 No 16 (16) 124 (20) 
 Unknown 20 (20) 96 (16) 
Geographical state NSW/ACT† 51 (50) 192 (31) 
 VIC‡ 16 (16) 168 (27) 
 QLD§ 17 (17) 106 (17) 
 SA|| 9 (9) 49 (8) 
 WA¶ 6 (6) 62 (10) 
 TAS** 3 (3) 19 (3) 
 NT†† 0 (0) 23 (4) 
      
Unit characteristics   (n=66) n (%) 
Unit size:      small  < 100 dialysis patients 34 (51) 
                     medium 100-199 dialysis patients 13 (20) 
                     large ≥ 200 dialysis patients 19 (29) 
Formal conservative care pathway Yes 10 (15) 
 
* Department of Veterans’ Affairs, †New South Wales / Australian Capital Territory, ‡
 
Victoria,  
§ Queensland, ||
 
South Australia, ¶
 
Western Australia, **
 
Tasmania, ††
 
Northern Territory.
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Table 2: Univariate and multivariable analyses for receiving information about conservative 
care as a treatment option versus not presented or unknown 
 
Characteristic Univariate (unadjusted)  
association 
Multivariable (adjusted) 
association 
 OR 95%CI p-value* OR 95% CI p-value* 
Treatment   0.013   0.567 
     RRT†  1.00 (referent)  1.00 (referent)  
     Conservative care 2.10 1.14-3.85  1.26 0.57-2.76  
       
Age (years)   <0.001   <0.001 
     < 65  1.00 (referent)  1.00 (referent)  
     65-74  2.91 1.83-4.64  3.40 1.97-5.87  
     75-84  4.08 2.53-6.56  5.55 3.08-10.02  
     ≥ 85  9.95 3.49-28.36  10.56 2.96-37.68  
       
Sex   0.717   0.596 
     Male  1.00 (referent)  1.00 (referent)  
     Female 0.94 0.66-1.33  0.89 0.59-1.35  
       
Insurance   0.132   0.700 
     Public only  1.00 (referent)  1.00 (referent)  
     Private 1.41 0.87-2.27  1.13 0.65-1.99  
     DVA‡ 3.03 0.95-9.66  2.14 0.50-9.09  
     Unknown 0.93 0.46-1.90  1.28 0.53-3.08  
       
Language spoken at home   0.001   0.077 
     English  1.00 (referent)  1.00 (referent)  
     Non-English, no interpreter 1.83 1.02-3.31  1.70 0.85-3.39  
     Non-English, interpreter 4.60 2.09-10.14  2.24 0.95-5.25  
       
Time known to a nephrologist   <0.001   <0.001 
     < 3 months  1.00 (referent)  1.00 (referent)  
     3-12 months 5.70 3.07-10.60  6.50 3.18-13.30  
     1-2 years 5.83 3.22-10.57  5.67 2.83-11.37  
     > 2 years 3.09 1.93-4.96  3.14 1.78-5.54  
       
Stage of CKD when info presented   <0.001   <0.001 
     Stage 5  1.00 (referent)  1.00 (referent)  
     Stages 2-4 1.51 1.00-2.29  1.01 0.61-1.64  
     Unknown 0.15 0.07-0.33  0.13 0.05-0.34  
       
Caregiver present   <0.001   <0.001 
     Yes  1.00 (referent)  1.00 (referent)  
     No 0.54 0.34-0.86  0.62 0.37-1.06  
     Unknown 0.13 0.08-0.23  0.20 0.11-0.37  
       
Unit has conservative care pathway   0.273   0.663 
     Yes  1.00 (referent)  1.00 (referent)  
     No 1.61 0.69-3.80  1.27 0.44-3.69  
       
Unit size (dialysis patients)   0.393   0.851 
     < 100  1.00 (referent)  1.00 (referent)  
     100-199 1.13 0.46-2.78  1.00 0.34-2.89  
     ≥200  0.66 0.30-1.43  0.78 0.30-2.03  
       
Intraclass correlation ρ=0.30, 95%CI (0.18-0.45) 
*Likelihood ratio, †Renal replacement therapy, ‡Department of Veterans’ Affairs. 
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Table 3: Characteristics of patients commencing conservative care versus renal replacement 
therapy; results of univariate and multivariable analyses  
 
Characteristic Univariate (unadjusted) 
association 
Multivariable (adjusted) 
association 
 OR 95%CI p-value* OR 95% CI p-value* 
Age (years)   <0.001   <0.001 
     < 65  1.00 (referent)  1.00 (referent)  
     65-74  4.23 1.66-10.78  4.71 1.77-12.49  
     75-84  18.35 7.91-42.59  23.11 9.46-56.47  
     ≥ 85  53.02 18.34-153.23  87.44 26.77-285.60  
       
Sex   0.076   0.007 
     Male  1.00 (referent)  1.00 (referent)  
     Female 1.55 0.96-2.51  2.23 1.23-4.02  
       
Insurance   0.081   0.021 
     Public only  1.00 (referent)  1.00 (referent)  
     Private 0.54 0.25-1.16  0.40 0.17-0.98  
     DVA
†
 1.61 0.50-5.20  0.23 0.05-0.96  
     Unknown 2.08 0.85-5.08  1.76 0.60-5.17  
       
Language spoken at home   0.185   0.740 
     English  1.00 (referent)  1.00 (referent)  
     Non-English, no interpreter 1.05 0.45-2.48  0.74 0.27-2.02  
     Non-English, interpreter 2.20 0.97-4.98  1.19 0.47-3.01  
       
Time known to a nephrologist   0.625   0.982 
     < 3 months  1.00 (referent)  1.00 (referent)  
     3-12 months 1.15 0.49-2.67  1.19 0.39-3.23  
     1-2 years 1.66 0.74-3.75  1.21 0.45-3.25  
     > 2 years 1.36 0.67-2.74  1.14 0.49-2.65  
       
Stage of CKD when info presented   0.049   0.112 
     Stage 5  1.00 (referent)  1.00 (referent)  
     Stages 2-4 1.86 1.08-3.19  1.99 1.04-3.80  
     Unknown 2.05 0.79-5.34  1.30 0.40-4.21  
       
Caregiver present   0.431   0.376 
     Yes  1.00 (referent)  1.00 (referent)  
     No 1.05 0.54-2.06  1.68 0.75-3.77  
     Unknown 1.54 0.81-2.95  1.44 0.62-3.37  
       
Unit has conservative care 
pathway 
  0.558   0.721 
     Yes  1.00 (referent)  1.00 (referent)  
     No 1.42 0.44-4.59  1.25 0.36-4.36  
       
Unit size (dialysis patients)   0.205   0.176 
     < 100  1.00 (referent)  1.00 (referent)  
     100-199 1.49 0.51-4.37  0.91 0.27-3.07  
     ≥200  0.56 0.21-1.48  0.36 0.12-1.12  
       
Intraclass correlation ρ=0.29, 95%CI (0.13-0.51) 
*Likelihood ratio, † Department of Veterans’ Affairs. 
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Table 4: Primary reason given by participating units as to why dialysis was not undertaken in 
the conservative care sub-group 
 
Primary reason n=102 (%) 
Frail / elderly 19 (19) 
Suitable but patient declined 27 (26) 
Co-morbid conditions (eg. metastatic malignancies, dementia) 25 (25) 
No dialysis access (vascular or peritoneal) possible 2 (2) 
No dialysis close to home and unable to perform a home therapy 1 (1) 
Not stated 28 (27) 
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Figure 1.  
Title: Study enrolment. Incidence of conservative care patients among Australian renal units 
over a three-month period 
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Figure 2.  
Title: Forest plot for odds of being presented with a conservative care treatment option. 
 Legend: Characteristics from multivariable model 1 with p<0.05 included. The dot represents 
the odds ratio and the bars represent the 95% confidence interval. The null has a value of 1 
(central dotted line) and the scale is logarithmic. 
 
 
  
 26 
 
Figure 3.  
Title: Forest plot for odds of commencing conservative care compared to renal replacement 
therapy.  
Legend: Characteristics from multivariable model 2 with p<0.05 included. The dot represents 
the odds ratio and the bars represent the 95% confidence interval. The null has a value of 1 
(central dotted line) and the scale is logarithmic. 
 
 
 
